We are really pleased to announce that AccuBio attended the Chinese British Business Council (CBBC) Chinese Burns Supper 2023 where we won our first company award.

This meeting was to sensitize members of the CSOs on the impact of Advanced HIV Disease (AHD) and the importance of identifying persons with AHD

Our 2nd site in Alva was completed during late 2022, this consisted of refitting existing local building to provide capacity of 2 warehouse areas and 1 central manufacturing area.

AccuBio has successfully installed five fully automated cassette and pouching machines . These are the first of a total of ten machines that will bring the overall capacity for lateral flow test production to 20,000 tests per hour. The system has inbuilt quality control features that ensures the highest of quality for every device produced and the ease of use and maintenance ensures a highly efficient process, These will be used to produce Respiratory and Infectious Disease lateral flow tests under the AccuSmart brand